Hohnloser SH - Search Results

1

Digoxin and Mortality in Patients With Atrial Fibrillation.

Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators. Lopes RD, et al. Among authors: hohnloser sh. J Am Coll Cardiol. 2018 Mar 13;71(10):1063-1074. doi: 10.1016/j.jacc.2017.12.060. J Am Coll Cardiol. 2018. PMID: 29519345 Free article. Clinical Trial.

2

Silent myocardial ischemia as a predisposing factor for ventricular fibrillation.

Hohnloser SH, Kasper W, Zehender M, Geibel A, Meinertz T, Just H. Hohnloser SH, et al. Am J Cardiol. 1988 Feb 15;61(6):461-3. doi: 10.1016/0002-9149(88)90306-2. Am J Cardiol. 1988. PMID: 3341229 No abstract available.

3

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.

Hohnloser SH, van de Loo A, Baedeker F. Hohnloser SH, et al. J Am Coll Cardiol. 1995 Oct;26(4):852-8. doi: 10.1016/0735-1097(95)00286-5. J Am Coll Cardiol. 1995. PMID: 7560608 Free article. Clinical Trial.

4

Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias.

Hohnloser SH, Klingenheben T, Zabel M, Just H. Hohnloser SH, et al. Am J Cardiol. 1993 Aug 12;72(4):67A-71A. doi: 10.1016/0002-9149(93)90027-a. Am J Cardiol. 1993. PMID: 8346729

5

Drug treatment of atrial fibrillation: what have we learned?

Hohnloser SH, Li YG. Hohnloser SH, et al. Curr Opin Cardiol. 1997 Jan;12(1):24-32. doi: 10.1097/00001573-199701000-00005. Curr Opin Cardiol. 1997. PMID: 9132077 Review.

6

Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications.

Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Credner SC, et al. Among authors: hohnloser sh. J Am Coll Cardiol. 1998 Dec;32(7):1909-15. doi: 10.1016/s0735-1097(98)00495-1. J Am Coll Cardiol. 1998. PMID: 9857871 Free article.

7

Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.

Hohnloser SH, Klingenheben T, Zabel M, Schöpperl M, Mauss O. Hohnloser SH, et al. J Am Coll Cardiol. 1999 Jun;33(7):1895-902. doi: 10.1016/s0735-1097(99)00108-4. J Am Coll Cardiol. 1999. PMID: 10362190 Free article.

8

Pharmacological therapy of atrial fibrillation.

Grönefeld G, Bender B, Li YG, Hohnloser SH. Grönefeld G, et al. Among authors: hohnloser sh. Thorac Cardiovasc Surg. 1999 Aug;47 Suppl 3:334-8. doi: 10.1055/s-2007-1013194. Thorac Cardiovasc Surg. 1999. PMID: 10520763 Review.

9

Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation.

Hohnloser SH. Hohnloser SH. Am J Cardiol. 1999 Nov 4;84(9A):56R-62R. doi: 10.1016/s0002-9149(99)00702-x. Am J Cardiol. 1999. PMID: 10568661 Review.

10

Pharmacological management of atrial fibrillation: an update.

Hohnloser SH, Li YG, Bender B, Grönefeld G. Hohnloser SH, et al. J Cardiovasc Pharmacol Ther. 2000 Jan;5(1):11-6. doi: 10.1177/107424840000500102. J Cardiovasc Pharmacol Ther. 2000. PMID: 10687669 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

550 results

Search Page